Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phil Inter Pharma is a prominent pharmaceutical manufacturer headquartered in Vietnam, operating as a subsidiary of the South Korean group Phil International. The company is widely recognized for its expertise in soft gelatin capsule (softgel) technology, alongside the production of hard capsules, tablets, and topical ointments. With manufacturing facilities certified under EU-GMP and WHO-GMP standards, Phil Inter Pharma serves both the domestic Vietnamese market and a growing list of international export destinations. In addition to its extensive portfolio of generic and over-the-counter (OTC) medicines, the company acts as a significant Contract Development and Manufacturing Organization (CDMO) for global pharmaceutical partners. Their focus on high-quality formulation and advanced manufacturing processes has established them as a leader in the Southeast Asian pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phil Inter Pharma.